Weekly Antepartum Testing in Women With BMI 30-40 and Neonatal Outcomes

Obesity Complicating Childbirth Clinical Trial

Official title: Does Weekly Antepartum Testing in Women With BMI 30-40 Improve Neonatal Outcomes: A Randomized Controlled Trial

Status Terminated

Clinical Trial Summary

The purpose of study is to evaluate whether weekly antenatal testing in pregnant women with body mass index (BMI) 30-40 in the third trimester is associated with earlier delivery when compared to growth ultrasounds every 4 weeks. The investigators will also assess the differences in maternal and neonatal outcomes between the groups.

Clinical Trial Description

Over the last decade, the prevalence of obesity has dramatically increased in women in reproductive age. It is well known that obesity has been associated with increased risk of antenatal complications, maternal and perinatal morbidity, including higher risk of stillbirth. Studies including obese women without other antepartum comorbidities have shown that up to 11% of pregnancies are complicated with fluid and fetal growth abnormalities. According to American College of Obstetricians and Gynecologists (ACOG) guidelines, antepartum surveillance has not been proven to improve pregnancy outcomes in such cases and no specific recommendations for antepartum surveillance in obese women have been established. ;

Related Conditions & MeSH terms

• Obesity Complicating Childbirth

• NCT number: NCT04180566
• Study type: Interventional
• Source: Columbia University
• Status: Terminated
• Phase: N/A
• Start date: February 4, 2020
• Completion date: March 10, 2021